Banco de Sabadell’s Dr. Reddy's Laboratories RDY Stock Holding History

Banco de Sabadell’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-58,425	Closed	-$715K	–	252
2021 Q1	$715K	Sell	58,425 -19,235	-25%	-$247K	0.07%	157
2020 Q4	$1.1M	Hold	77,660	–	–	0.12%	143
2020 Q3	$1.07M	Hold	77,660	–	–	0.12%	177
2020 Q2	$824K	Hold	77,660	–	–	0.11%	146
2020 Q1	$624K	Hold	77,660	–	–	0.1%	171
2019 Q4	$632K	Sell	77,660 -32,075	-29%	-$253K	0.08%	188
2019 Q3	$850K	Hold	109,735	–	–	0.12%	162
2019 Q2	$822K	Hold	109,735	–	–	0.1%	187
2019 Q1	$879K	Hold	109,735	–	–	0.12%	162
2018 Q4	$827K	Hold	109,735	–	–	0.1%	192
2018 Q3	$763K	Buy	109,735 +25,500	+30%	+$170K	0.08%	223
2018 Q2	$545K	Hold	84,235	–	–	0.07%	268
2018 Q1	$549K	Buy	+84,235	New	+$590K	0.07%	276

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Banco de Sabadell's RDY Position: Q2 2021 in Review

Banco de Sabadell sold out of Dr. Reddy's Laboratories (RDY) in Q2 2021, closing a stake of 58,425 shares — an estimated $715K sold.

Banco de Sabadell first reported a position in RDY in Q1 2018 and held it in 13 quarters. The position peaked at $1.1M in Q4 2020. 161 funds tracked by Wall St. Rank hold RDY as of Q2 2021.

Banco de Sabadell reported no remaining Dr. Reddy's Laboratories position as of Q2 2021 after selling out during the quarter.
Banco de Sabadell sold 58,425 Dr. Reddy's Laboratories shares in Q2 2021, an estimated $715K.
Banco de Sabadell first reported a position in Dr. Reddy's Laboratories in Q1 2018 and held it in 13 quarters.
Banco de Sabadell's Dr. Reddy's Laboratories position peaked at $1.1M in Q4 2020.
161 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2021.

Based on Banco de Sabadell's 13F filing for Q2 2021, filed 13 Aug 2021.